A rare case of acquired factor V inhibitor, during treatment with dabigatran for chronic atrial fibrillation, successfully treated with bypassing agents

Abstract

Abstract Acquired factor V inhibitor represents a rare condition, described only in case reports. The use of activated bypassing agents in bleeding control could be of aid and improve the survival in symptomatic patients with acquired factor V inhibitor.

Keywords

• acquired coagulation inhibitor
• bypassing agents
• dabigatran
• factor V
• immunosuppressive therapy